+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues



Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues



Gene Therapy 6(2): 162-170



Introduction of the herpes simplex virus type 1 thymidine kinase gene into tumor cells, followed by the administration of the antiherpes nucleoside analogue ganciclovir has been demonstrated to be effective in eliminating solid tumors in animals. The success of this combination treatment largely depends on the bystander effect, i.e. the killing of nontransfected tumor cells by activated drug carried over from the nearby herpes thymidine kinase (tk) gene-transfected cells. We evaluated the in vitro bystander effect of several antiherpes purine and pyrimidine nucleoside analogues, using a colorimetric assay. All pyrimidine nucleoside analogues, including (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), showed low, if any, bystander killing effect. In contrast, purine nucleoside analogues, such as ganciclovir, were endowed with a pronounced bystander killer effect. Lobucavir (Cyclobut-G), a ganciclovir analogue, displayed a two- to three-fold more pronounced bystander killer effect than gancic lovir, eliminating, at a concentration of 10 muM, 75% and 90% of a cell population that contained 5% and 10% tk gene-transfected cells, respectively. These findings were corroborated by autoradiographic analysis that showed that 2'-3H-BVDU metabolites formed in the herpes tk gene-transfected tumor cells were much less efficiently incorporated in the DNA of bystander cells than 8-3H-GCV. This indicates that, under the same experimental conditions, BVDU metabolites are less prone to pass the gap junctions than GCV metabolites.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010261109

Download citation: RISBibTeXText


Related references

Synthesis of new pyrimidine and purine C-nucleoside analogues. Abstracts of Papers American Chemical Society 208(1-2): CARB 23, 1994

New nucleoside analogues for the recognition of pyrimidine-purine inversion sites. Nucleosides Nucleotides and Nucleic Acids 22(5-8): 1199-1201, 2003

A New and Versatile Synthesis of 1,3-Dioxan-5-yl-pyrimidine and Purine Nucleoside Analogues. Synlett 26(05): 625-630, 2015

Targets for the antiviral activity of pyrimidine and purine nucleoside analogues. Nucleosides and Nucleotides 6(1-2): 197-208, 1987

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy. Hospital Practice 27(Suppl. 2): 14-25, 1992

Anti-flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside Analogues. Chemistryopen 5(3): 227-235, 2016

Antiviral acyclic nucleoside phosphonate analogues as inhibitors of purine nucleoside phosphorylase. Advances in Experimental Medicine and Biology 431: 747-752, 1998

Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors. Biochemical Pharmacology 36(22): 3815-3822, 1987

Characterization of pyrimidine nucleoside phosphorylase of Mycoplasma hyorhinis: implications for the clinical efficacy of nucleoside analogues. Biochemical Journal 445(1): 113-123, 2012

Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review. Pharmacy World and Science 16(2): 127-138, 1994

Synthesis of purine and 7-deazapurine nucleoside analogues of 6-N-(4-Nitrobenzyl)adenosine; inhibition of nucleoside transport and proliferation of cancer cells. Chemmedchem 9(9): 2186-2192, 2014

Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans. Chembiochem 4(8): 742-747, 2003

Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae. Biochemistry and Cell Biology 80(5): 639-644, 2002

Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus. Biochemical Pharmacology 51(6): 731-736, 1996

Nucleoside analogues 9. seco nucleoside analogues of some 5 fluorouracil nitrosourea molecular combinations having uracil as base synthesis and anti tumor activity. Anti Cancer Drug Design 4(3): 191-208, 1989